Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. - Wikidata - wikimedia - TriplyDB

Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.

Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.

http://www.wikidata.org/entity/Q38986075

about

Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease Mesenchymal stem cells and immunomodulation: current status and future prospects Stem cell-based regenerative opportunities for the liver: State of the art and beyond Mesenchymal stem cell therapy for liver fibrosis Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis Bone marrow derived stem cells for the treatment of end-stage liver disease Autologous bone marrow-derived cells in the treatment of liver disease patients Concise review: bone marrow autotransplants for liver disease?Systematic review: the effects of autologous stem cell therapy for patients with liver disease Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure.Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury.Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta.Therapeutic potential of mesenchymal stem cells in regenerative medicine Ex Vivo Stromal Cell-Derived Factor 1-Mediated Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells into Hepatocytes Is Enhanced by Chinese Medicine Yiguanjian Drug-Containing Serum.Effect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis.Stem cells in liver regeneration and their potential clinical applications.Immunological basis of stem cell therapy in liver diseases.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.Stem Cell Therapy: Current Applications and Potential for Urology.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.Progress in stem cell-based therapy for liver disease.Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.Therapeutic application of multipotent stem cells.In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential.In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice.Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.Cell-Based Therapies for Tissue Fibrosis.Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.A case report of congenital glycogen storage liver cirrhosis treated with bone marrow derived stem cells.Stem cell therapy for the treatment of parasitic infections: is it far away?Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.

P2860

Q26769618-A860A9A5-3EC1-40F9-928B-C434B83D220F Q26770191-17D5E104-C464-4ACE-B5A3-90E7CD960576 Q26775924-D3E97CCE-FD7E-41AD-9A22-35F47BADDFC8 Q26782128-5102A540-66F3-4174-A454-442E1D7572E1 Q26783606-E04AC841-F7B8-4A82-B425-CAA8235B3BE4 Q26801163-33B108B5-A3D5-47D2-845A-94C1BC87499A Q26850412-B8D0F47D-6127-41E3-A451-E7685BF9F627 Q26863284-8603CA29-A972-4AA6-9F8A-A9C975C463B0 Q27010009-DBFC229A-D595-4F4A-AFF2-7367B0F67EC3 Q27024968-72F8D21A-C2CE-46F8-8595-4CE233689928 Q33767742-8C8081F0-3A0A-4446-B655-949213BA967F Q34194760-38E2D71A-F6E2-418B-A361-DEC78F1CA3E4 Q34516477-0ADC7A1E-E8B8-4A32-A127-4095B3F0F11B Q34985947-783BE854-A5BB-48A6-B42D-9F71C9D3BC37 Q35409945-45DF825E-006B-4EAD-862E-737BB22DEBEF Q36287523-E68F5A5D-12DD-4555-8B47-7764157A4B29 Q36737833-E59F792A-B2BF-457A-A396-E98ECD0E9339 Q36845499-880D2002-5F00-482D-B1E1-CCF5E7DE998D Q37654580-ACCF99B1-10F5-4BD7-8270-FD7617267F20 Q38092746-D7D1E892-6A41-4FB7-8091-2152B3D26D65 Q38223210-07A68ACC-F0FF-4F5B-8084-2B24904C3DE1 Q38393820-0885BA2D-2EE9-459D-A68E-8D9733E786D4 Q38414766-4BF99077-9928-4EBA-8F79-553DB8413D06 Q38589422-89422ADD-C5E8-4DF7-A63D-46C8FBBD5362 Q38675565-E21DA8AD-0222-45B9-BB1D-4B5E39575104 Q38772557-E3DD68D4-92ED-4058-8F03-0634C91CAAB3 Q38820953-A3ED691C-1075-4838-8E6E-F13BE98DEE4A Q38836460-5BB90075-035C-4427-9E53-2129E6F8636B Q39143427-3564A63F-D361-492B-A0AC-ED8BF38EEBD9 Q39285733-3E883690-156D-46DF-BB3A-2F601B1909EF Q39410484-BA1B59C0-66D5-4642-B2BC-237D8B1E33A3 Q39441667-7087B989-7D51-4037-AABB-3F7EB2AFB2B8 Q41922753-F808AFEB-1770-4D8B-99BF-AF132296E58F Q42211281-A6CF04D1-DA9C-4748-A129-97C327783803 Q42369905-5DD908F6-FE31-4CD4-8E0E-DB66B71DC48E Q42585736-E9B8C041-1E72-4F27-8782-DA1D2DB736A7 Q42800214-87DAF811-CCE5-47BE-B2D0-6DBE6C92EB3D Q44115782-AE915ECC-B702-4C9C-AD9F-F850C1748957 Q46177862-825C192C-8073-4834-B4D6-6482EEE2CF84 Q47150689-3940DC60-0D61-463B-98B1-1D946AEAB12B

P2860

Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.

http://www.wikidata.org/entity/Q38986075

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.

@en

type

label

Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.

@en

prefLabel

Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.

@en

P1433

Q38986075-FBB6EA66-C7EB-467C-B313-FCA0558D63EE

P1476

Q38986075-2CE6AC0C-F1BA-4164-A5B1-D761E08EE6D0

P2093

Q38986075-09E48649-683D-49B2-B468-8DEB14F84BAD

Q38986075-0A2835A4-FC17-44B1-86D4-C67978F21182

Q38986075-1E1ECA13-5481-478C-B867-6B1EBBDFF58C

Q38986075-26D031C7-48B8-4FA9-9405-0A9AE0A9D4D4

Q38986075-37702400-D31A-4E2D-B447-48B34CD877CA

Q38986075-3C0C6211-5EAD-4022-AAB5-9CC6774F1EEF

Q38986075-4D072A18-3D83-4422-977A-9D611BFD35A0

P2860

Q38986075-09DA4796-2D91-45C0-AED6-8DAADAB69E30

Q38986075-0B38D7B3-8BB9-4C0D-A5BB-1E6CAA5A14AB

Q38986075-0BC09EAF-6B36-4D10-A907-31AF243BD817

Q38986075-16BC772E-113A-43C7-A7C4-D1162A474565

Q38986075-2530A5ED-7888-41E6-ADF3-332A076D3A7E

Q38986075-297545F6-7BC7-49BC-8261-0F16CADB7D79

Q38986075-2B8E1CA2-67BE-404E-B051-72347224BC45

Q38986075-3DB0959A-3439-4C7D-B2FD-8CD645B72A27

Q38986075-42924824-4BD7-4F32-9D17-E9170FD49E21

Q38986075-4E14408A-50A9-457B-AD35-56F65B53E3A7

P2888

Q38986075-8CE4C42C-A98C-462D-A260-1720A391C87C

P304

Q38986075-C70188BF-0465-4493-A749-9F6766D754CB

P31

Q38986075-872E23A1-FEFA-45D0-BF59-632FEB8048D1

P356

Q38986075-65A33762-BD73-4FFF-8EB3-841BFF67BC54

P433

Q38986075-5F8F6560-27B4-4EE7-BEE0-A9F6E8F139B8

P478

Q38986075-1BD2928C-1386-4045-91F0-B6D8FB29112C

P577

Q38986075-DA21D162-44AC-4EF1-959C-AA6AEDF2C668

P6179

Q38986075-5342C311-4556-400F-8242-792A3979F549

P698

Q38986075-91DF8BF8-74D9-489B-8FBA-6AAD01000179

P921

Q38986075-AB2902DF-192B-4857-A5DA-C07A673A5533

Q38986075-BDA17D15-DF64-426B-A08F-DF89BC7CBC2C

P356

S12015-011-9322-Y

P1433

Stem Cell Reviews and Reports

P1476

Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.

@en

P2093

Iman Abdel-Aziz

http://www.w3.org/2001/XMLSchema#string

Marwa Wahdan

http://www.w3.org/2001/XMLSchema#string

Mervat El-Ansary

http://www.w3.org/2001/XMLSchema#string

Olfat Hammam

http://www.w3.org/2001/XMLSchema#string

Salwa Teaema

http://www.w3.org/2001/XMLSchema#string

Samah Abdel-Hamid

http://www.w3.org/2001/XMLSchema#string

Sherif Mogawer

http://www.w3.org/2001/XMLSchema#string

P2860

Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy

Stem cells and their potential in cell-based cardiac therapies

The profile of gene expression of human marrow mesenchymal stem cells.

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

Ischemic rat brain extracts induce human marrow stromal cell growth factor production.

Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats

Bone marrow stem cells contribute to repair of the ischemically injured renal tubule

Treatment of neural injury with marrow stromal cells.

Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine

Gastrointestinal stem cells. III. Emergent themes of liver stem cell biology: niche, quiescence, self-renewal, and plasticity.

P2888

s12015-011-9322-y

P304

972-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12015-011-9322-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026199217

http://www.w3.org/2001/XMLSchema#string

P698

21989829

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

phase II clinical trial